These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

619 related items for PubMed ID: 9211017

  • 1. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
    Ruffolo RR, Feuerstein GZ.
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():247-56. PubMed ID: 9211017
    [Abstract] [Full Text] [Related]

  • 2. Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection.
    Feuerstein GZ, Ruffolo RR.
    Eur Heart J; 1996 Apr; 17 Suppl B():24-9. PubMed ID: 8733068
    [Abstract] [Full Text] [Related]

  • 3. Protective effects of carvedilol in the myocardium.
    Feuerstein GZ, Bril A, Ruffolo RR.
    Am J Cardiol; 1997 Dec 04; 80(11A):41L-45L. PubMed ID: 9412541
    [Abstract] [Full Text] [Related]

  • 4. Vasodilatory action of carvedilol.
    Sponer G, Strein K, Bartsch W, Müller-Beckmann B.
    J Cardiovasc Pharmacol; 1992 Dec 04; 19 Suppl 1():S5-11. PubMed ID: 1378150
    [Abstract] [Full Text] [Related]

  • 5. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
    Feuerstein GZ, Yue TL, Cheng HY, Ruffolo RR.
    J Hypertens Suppl; 1993 Jun 04; 11(4):S41-8. PubMed ID: 8104241
    [Abstract] [Full Text] [Related]

  • 6. Myocardial protection with carvedilol.
    Feuerstein GZ, Hamburger SA, Smith EF, Bril A, Ruffolo RR.
    J Cardiovasc Pharmacol; 1992 Jun 04; 19 Suppl 1():S138-41. PubMed ID: 1378142
    [Abstract] [Full Text] [Related]

  • 7. Recent observations with beta-adrenoceptor blockade. Beneficial effects in hypertension and heart failure.
    Ruffolo RR, Feuerstein GZ, Ohlstein EH.
    Am J Hypertens; 1998 Jan 04; 11(1 Pt 2):9S-14S. PubMed ID: 9503101
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Beta-blockers in congestive heart failure: the pharmacology of carvedilol, a vasodilating beta-blocker and antioxidant, and its therapeutic utility in congestive heart failure.
    Feuerstein G, Ruffolo RR.
    Adv Pharmacol; 1998 Jan 04; 42():611-5. PubMed ID: 9327976
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effects of intravenous carvedilol, a new multiple action vasodilatory beta-blocker, in congestive heart failure.
    DasGupta P, Broadhurst P, Lahiri A.
    J Cardiovasc Pharmacol; 1991 Jan 04; 18 Suppl 4():S12-6. PubMed ID: 1721973
    [Abstract] [Full Text] [Related]

  • 15. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.
    Bril A, Slivjak M, DiMartino MJ, Feuerstein GZ, Linee P, Poyser RH, Ruffolo RR, Smith EF.
    Cardiovasc Res; 1992 May 04; 26(5):518-25. PubMed ID: 1359930
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.